DSDani A. Szafran

Dani A. Szafran

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Dani A. Szafran has a total of 25 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Matrix-designed bright near-infrared fluorophores for precision peripheral nerve imaging

    by Antonio R. Montaño, Anas Masillati, Dani A. Szafran, Nourhan A. Shams, Grace E. Hubbell, Connor W. Barth, Summer L. Gibbs, Lei G. Wang


  • Open Access

    Two-color fluorescence-guided surgery for head and neck cancer resections

    by Dani A. Szafran, Nourhan A. Shams, Antonio Montaño, Syed Zaki Husain Rizvi, Adam W.G. Alani, Kimberley S. Samkoe, Lei G. Wang, Summer L. Gibbs

    Head and neck squamous cell carcinoma (HNSCC) is the sixth most prevalent cancer type, with >650,000 cases diagnosed annually worldwide.1,2 Surgical cancer resection remains the preferred treatment for HNSCC,3,4 where the surgeon balances two main challenges: (1) complete surgical resection and (2) preservation of nerves to reduce pain and maintain function. The most important factor for predicting long-term survival following surgery is the completeness of cancer resection.5 – 7 However, identifying tumors and normal tissues during surgery remains challenging, and positive surgical margins occur in 15% to 30% of patients, resulting in poor outcomes and additional therapy.8,9 Furthermore, additional malignancies are often present and undetected during surgery, representing the second leading cause of death in HNSCC patients.10 Secondary to cancer treatment, surgical outcomes are plagued by intraoperative nerve damage, causing lasting pain and loss of function, significantly affecting patient postoperative quality of life. Important cranial, spinal, and facial nerves are small, and translucent structures often buried within tissue, making them difficult to consistently identify and visualize, leading to nerve damage.11 – 14 As a result, a number of comorbidities, including severe pain, dysphagia, and jaw and sensory dysfunction, are experienced by >40% of patients.15 Unfortunately, achieving complete cancer resection while simultaneously preserving important nerves in the head and neck region remains difficult, where efforts to preserve normal anatomy and function limit cancer resection margins. Thus, current intraoperative cancer and nerve detection techniques, generally consisting of preoperative imaging, biopsy, intraoperative neuromonitoring, and visual inspection, fall far short of meeting the clinical need.16


  • Development of near-infrared fluorophores for improved nerve-sparing surgical procedures

    by Lei G. Wang, Connor Barth, Antonio Montaño, Anas Masillati, Dani Szafran, Summer L. Gibbs

    Fluorescence-guided surgery (FGS) has the potential to significantly enhance patient outcomes by enabling precise real-time visualization of vital nerve structures during surgical procedures. However, a clinically approved nerve-specific contrast agent does not exist. To address this need, we adopted a medicinal chemistry approach to design and develop novel near-infrared (NIR) nerve-binding small molecule fluorophore libraries. Our first-in-class NIR nerve-binding small molecule fluorophores represent a significant advancement in the field. By enabling precise nerve visualization in real-time during surgery, these contrast agents have the potential to revolutionize nerve-sparing procedures and ultimately improve patient outcomes.

  • Open Access

    Publisher Correction: OregonFluor enables quantitative intracellular paired agent imaging to assess drug target availability in live cells and tissues

    by Lei G. Wang, Antonio R. Montaño, Jason R. Combs, Nathan P. McMahon, Allison Solanki, Michelle M. Gomes, Kai Tao, William H. Bisson, Dani A. Szafran, Kimberley S. Samkoe, et al.


  • OregonFluor enables quantitative intracellular paired agent imaging to assess drug target availability in live cells and tissues

    by Lei G. Wang, Antonio R. Montaño, Jason R. Combs, Nathan P. McMahon, Allison Solanki, Michelle M. Gomes, Kai Tao, William H. Bisson, Dani A. Szafran, Kimberley S. Samkoe, et al.

    Non-destructive fluorophore diffusion across cell membranes to provide an unbiased fluorescence intensity readout is critical for quantitative imaging applications in live cells and tissues. Commercially available small-molecule fluorophores have been engineered for biological compatibility, imparting high water solubility by modifying rhodamine and cyanine dye scaffolds with multiple sulfonate groups. The resulting net negative charge, however, often renders these fluorophores cell-membrane-impermeant. Here we report the design and development of our biologically compatible, water-soluble and cell-membrane-permeable fluorophores, termed OregonFluor (ORFluor). By adapting previously established ratiometric imaging methodology using bio-affinity agents, it is now possible to use small-molecule ORFluor-labelled therapeutic inhibitors to quantitatively visualize their intracellular distribution and protein target-specific binding, providing a chemical toolkit for quantifying drug target availability in live cells and tissues.